Sofinnova Management VIII
Latest statistics and disclosures from Sofinnova Management VIII's latest quarterly 13F-HR filing:
- Top 5 stock holdings are NCNA, Obseva Sa, ACRS, Spark Therapeutics, NTRA, and represent 92.91% of Sofinnova Management VIII's stock portfolio.
- Added to shares of these 2 stocks: NCNA (+$40M), Obseva Sa (+$9.8M).
- Sofinnova Management VIII was a net buyer of stock by $50M.
- Sofinnova Management VIII has $183M in assets under management (AUM), dropping by 11.69%.
- Central Index Key (CIK): 0001559565
Tip: Access up to 7 years of quarterly data
Positions held by Sofinnova Management VIII consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sofinnova Management VIII
Sofinnova Management VIII holds 8 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Nucana Plc american depositary shares (NCNA) | 25.8 | $47M | +600% | 4.7M | 10.11 |
|
| Obseva Sa | 25.3 | $46M | +26% | 4.7M | 9.76 |
|
| Aclaris Therapeutics (ACRS) | 20.7 | $38M | 1.5M | 24.66 |
|
|
| Spark Therapeutics | 13.5 | $25M | 481k | 51.42 |
|
|
| Natera (NTRA) | 7.6 | $14M | 1.6M | 8.99 |
|
|
| Auris Med Hldg | 2.5 | $4.6M | 7.8M | 0.59 |
|
|
| Histogenics Corp Cmn | 2.3 | $4.3M | 2.1M | 2.05 |
|
|
| Synlogic | 2.2 | $4.1M | 425k | 9.70 |
|
Past Filings by Sofinnova Management VIII
SEC 13F filings are viewable for Sofinnova Management VIII going back to 2016
- Sofinnova Management VIII 2017 Q4 filed Feb. 14, 2018
- Sofinnova Management VIII 2017 Q3 filed Oct. 11, 2017
- Sofinnova Management VIII 2017 Q2 filed July 19, 2017
- Sofinnova Management VIII 2017 Q1 filed April 10, 2017
- Sofinnova Management VIII 2016 Q4 filed Feb. 14, 2017